Chunjuan Zheng

Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate Immunotherapy

Yu Liu, Zaigang Zhou, Ji-Ting Hou et al. · Advanced Materials · 2022 · 117 citations · Full text

Immunology, Chemical Biology, Immunotherapy +23

Metformin modified chitosan as a multi-functional adjuvant to enhance cisplatin-based tumor chemotherapy efficacy

Zaigang Zhou, Yu Liu, Xin Jiang et al. · International Journal of Biological Macromolecules · 2022 · 93 citations

Oncology, Polymer-drug Conjugate, Medicine +7

Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy

Zaigang Zhou, Jiashe Chen, Yu Liu et al. · Acta Pharmaceutica Sinica B · 2022 · 73 citations · Full text

Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy

Jiashe Chen, Zaigang Zhou, Chunjuan Zheng et al. · Carbohydrate Polymers · 2021 · 49 citations

Cancer Immunosurveillance, Cancer Chemoimmunotherapy, Pd-l1 Expression +8

Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy

Zaigang Zhou, Ning Jiang, Jiashe Chen et al. · Journal of Nanobiotechnology · 2021 · 47 citations · Full text